June 4, 2021
Member/Center Highlights
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
American Society of Clinical Oncology Annual Meeting 2021: Highlights from the Case CCC
The American Society of Clinical Oncology (ASCO) Annual Meeting will be held virtually again this year, June 4-8, 2021. The meeting will feature a dynamic program of educational and scientific sessions, showcasing what is possible when the cancer care community comes together to advance cancer research, treatment, and patient care. On-demand content and presentations will be available beginning at 9:00 am ET on Friday, June 4, while a scheduled broadcast experience featuring 48 high-impact sessions with real-time engagement and live Q&A is planned for all registrants.

The Case Comprehensive Cancer Center has compiled a list of ancillary educational events, oral abstract sessions, poster and poster discussion sessions, as well as publication-only abstracts from Cleveland-based institutions including Case Western Reserve University, University Hospitals, Cleveland Clinic and The MetroHealth System.
Gullett named to Crain's Women of Note
The Case Comprehensive Cancer Center (Case CCC) extends congratulations to Heidi Gullett, MD, MPH, who will be recognized at the 2021 Crain's Cleveland Business' Women of Note Awards. This year's event salutes 15 inspiring women whose dedication and achievements enrich Northeast Ohio, its institutions, and its people and will be held virtually at 4 pm ET on Wednesday, July 21.

Dr. Gullett is Associate Director, Center for Community Health Integration at Case Western Reserve University School of Medicine and a member of the Case CCC's Population and Cancer Prevention Program. Register to attend the virtual event here.
Tiwari receives SIIM Early Career Achievement Award
Congratulations to Pallavi Tiwari, PhD, recipient of the Society for Imaging Informatics in Medicine (SIIM) Early Career Achievement Award! The 2021 Honorary Award is presented in recognition of significant and innovative technical contributions in imaging informatics.

Dr. Tiwari is an assistant professor of biomedical engineering at Case School of Engineering and a member of the Case Comprehensive Cancer Center's Cancer Imaging Program.
Recorded presentations from NCCN 2021 Virtual Conference now available
More than 35 recorded educational sessions from the National Comprehensive Cancer Network 2021 Virtual Annual Conference are now available, with up to 34 credits/contact hours of education spanning a variety of disease areas, survivorship, disparities, and the pandemic are accessible!
National Cancer Institute Requests for Information: Enhancing Cancer Health Disparities Research and Diversity and Inclusion in the Cancer Research Workforce
NCI Logo
The National Cancer Institute (NCI) Equity and Inclusion Program seeks actionable recommendations to enhance cancer health disparities research and diversity and inclusion in the cancer research workforce through the following two Requests for Information (RFIs).

Jennifer Cullen, PhD, MPH (jxc1650@case.edu) and Erika Trapl, PhD (erika.trapl@case.edu) are coordinating a response on behalf of the Case Comprehensive Cancer Center, and welcome your feedback and comments.

Go #CWRUALLinTogether for Cancer Research on Tuesday, June 8
Tuesday, June 8 marks Case Western Reserve University's annual Day of Giving, which empowers alumni, students, faculty, staff, family and friends from across the globe to go #CWRUALLinTogether to support academic success, student scholarships, research, emergency student funds, COVID-19-related initiatives and more!

The Case Comprehensive Cancer Center's Innovation Fund is among one of the funds being featured by the School of Medicine. Contributors may designate their gift to the fund by clicking "Give Now!" followed by selecting "School of Medicine" in the drop-down menu, and then "Case Comprehensive Cancer Center Innovation Fund" in the final designation drop-down.
What's Coming Up
Mark Your Calendar
Register Today for the Annual Scientific Retreat
July 22-23, 2021 | Virtual
The 2021 Annual Scientific Retreat for members and trainees is scheduled for July 22-23! As you may know, this is one of the few times a year our entire center is able to enjoy the company of one another and collaborate.

This year's virtual retreat features an expanded agenda that mirrors our prior in-person retreats, highlighting research across each of our scientific programs.

The retreat will begin Thursday with an address from Director Stan Gerson, MD, followed by TED-style Talks from Diana Bilimoria, PhD, Daniel E. Spratt, MD, and Serpil Erzurum, MD. Registration for the retreat is now open.
Zihai Li
Zihai Li, MD, PhD will present the retreat keynote on Friday, July 23. Dr. Li is the founding director of the Pelotonia Institute for Immuno-Oncology and the Klotz Chair in Cancer Research at The Ohio State University.
Register today for VeloSano 8!
Bike to Cure Weekend | September 10-12, 2021
We are looking ahead with optimism to VeloSano 8 with a goal of providing opportunities to reunite our VeloSano community in a variety of safe and meaningful ways!

VeloSano is offering options for anyone to participate in any way they are most comfortable - whether riding with us during "Bike to Cure" weekend September 10-12; riding virtually, or by choosing your own activity to participate anytime, anywhere as a Virtual Fundraiser.

The Case Comprehensive Cancer Center, Team Case CCC, will be joining VeloSano again this year and providing complimentary registration and jerseys for its riders. Please contact team captains Caroline El Sanadi or Mary Wright for the registration waiver or code with any questions!
Save the Date: Great Lakes Breast Cancer Symposium
October 25-26, 2021 | Virtual
Save the date for the Great Lakes Breast Cancer Symposium, to be held virtually October 25-26, 2021!

This annual symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.

Though this event is happening virtually, attendees will experience the conference using Whova, our official web-based conference app, to view presentations and ask questions in real-time, as well as network with others behind the scenes.
Helen Piwnica Worms
Helen Piwnica-Worms, PhD, will deliver a keynote at the symposium. Dr. Piwnica-Worms is Professor, Department of Experimental Radiation Oncology, Division of Radiation Oncology and Senator AM Aiken Jr. Distinguished Chair at University of Texas MD Anderson Cancer Center.

Registration and call for abstracts for this symposium will open June 2021.
Additional Upcoming Events
NCCN Policy Summit: Defining the "New Normal"
June 15, 2021 | Virtual
Registration is now open for the next National Comprehensive Cancer Network (NCCN) policy summit: Defining the "New Normal" - 2021 and the State of Cancer Care in America Following 2020, held virtually Tuesday, June 15, 2021.

This FREE online program will explore how national health and sociopolitical events in 2020 will impact future cancer care delivery in the United States. Convening a group of diverse speakers and panelists, the virtual summit will discuss the influence of watershed events including the COVID-19 pandemic, post-election landscape, and national conversations of racial inequity on cancer care. Learn more about upcoming NCCN summits.
Women in Data Science (WiDS) Cleveland
June 30, 2021 | Virtual 1:15-4:45p ET
The Cleveland Institute for Computational Biology (CICB) and the Department of Population and Quantitative Health Sciences (PQHS) are excited to host the first annual Women in Data Science (WiDS) Cleveland event on Wednesday, June 30, from 1:15 pm - 4:45 pm.

The Global Women in Data Science (WiDS) initiative aims to inspire and educate data scientists worldwide, regardless of gender, and to support women in the field.

WiDS Cleveland is an independent event organized by the WiDS Cleveland team as part of the annual WiDS Worldwide conference organized by Stanford University and an estimated 150+ locations worldwide, featuring outstanding women doing work in the field of data science. All genders are invited to attend all WiDS Worldwide conference events.

The inaugural WiDS Cleveland 2021 will be held virtually via the Gather.town platform as a casual gathering providing an opportunity to hear about the latest data science-related research in a number of domains, learning how leading-edge companies are using data science for success, and connecting with potential mentors and collaborators in the field. All are invited to attend.

AACI Clinical Research Innovation 13th Annual Meeting
July 13-15, 2021 | Virtual
Registration is now open for the 13th Annual AACI CRI Meeting, Adapting Clinical Trials Offices for 2021 and Beyond which will be held virtually July 13-15. The program will provide panel discussions with content experts and breakout sessions for our members and abstract winners and runners-up will be acknowledged in poster sessions.

More information, including the program and registration, is now available on the CRI meeting website.
Midwest Melanoma and High Risk Skin Cancer Symposium
July 16, 2021 | Live Stream 8a-1:15p ET
This half day CME accredited symposium is specifically designed to provide those who have skin cancer management interests the latest advances in prevention, surveillance, and local-regional and systemic therapies.

This activity will bring together an audience of medical oncologists, radiation oncologists, surgeons, dermatologists, nurses, and other health care providers to discuss management of these patients.

Click here to view the symposium agenda. Registration includes access to presentations for 3 months after program.
National Cancer Institute Logo
NCI Drug Development Workshop Series: How to Advance A Therapeutic Candidate from Bench to Bedside
July 23, 2021 - December 10, 2021
This workshop being sponsored by the Developmental Therapeutics Program at the NCI will entail a series of 10 webinar-based lectures held Friday afternoons (12-2:30 pm ET) July 23, 2021 through December 10, 2021. The goal of this workshop is to provide researchers with an interactive setting in which they will gain an understanding of product development considerations for anti-cancer therapeutics, to facilitate successful translation from preclinical to clinical studies.

This workshop is specifically designed for researchers who are interested in learning about key activities that are needed to take their discoveries from the lab to the clinic. Junior faculty and trainees are encouraged to attend.

Workshop topics will encompass key IND-enabling activities and milestones, regulatory considerations, as well as contemporary first-in-human trial design, available NCI translational resources, insights from the private sector for entrepreneurial purposes, and case studies. Each session includes facilitated questions and answers (Q&A) to engage audience in the discussion.

Session recordings will be made available to the public at the registration site. Registration is not required for accessing the recordings. Please note that while you may register for one or multiple sessions, attendance for all sessions is encouraged to gain the maximal learning and benefit.

8th Annual Genetics Education Symposium
September 30, 2021 | Live Stream 8a-4:45p ET
This accredited program, presented by Cleveland Clinic’s Genomic Medicine Institute (GMI) and the Center for Personalized Genetic Healthcare (CPGH), will provide the opportunity to review the latest advances in genetics and genomics. GMI and CPGH will provide state-of-the-art information to healthcare providers treating patients with hereditary cancer syndromes.

Expert Cleveland Clinic and guest faculty will present case- and research-based presentations highlighting the integration of genetics and genomics into clinical practice.

Invited are practitioners and healthcare professionals seeking to learn the latest developments in medical genetics, especially providers in Hematology/Oncology, Genetics, Internal Medicine and Subspecialties, Pediatrics, and Nursing. Trainees and students with an interest in expanding their knowledge of genomic medicine and related topics are also encouraged to attend.

Funding Opportunities
CDMRP logo
The Department of Defense and its Congressionally Directed Medical Research Programs (CDMRP) have announced program details and application instructions for the following FY2021 program:

  • Melanoma Academy Leadership Award
  • Melanoma Academy Scholar Award
Together with the Rising Tide Foundation for Clinical Cancer Research, the Anticancer Fund seeks to support clinical trials testing novel and unique strategies in the treatment of patients diagnosed with pancreatic ductal adenocarcinomas (PDAC) and/or biliary tract cancer (BTC). Proposals must have the potential to have a high impact (e.g. improve cure rate or survival) on the treatment of these cancers.
With the generous support from VeloSano Bike to Cure 2020, the Case Comprehensive Cancer Center (Case CCC) is providing seed funding for innovative and impactful proposals that will generate key data for larger, nationally competitive multi-investigator/team grants (MPI R01, P01, U01, SPORE, etc.). The Case CCC has recently undertaken a reorientation of its scientific programs, and this award will provide funds for each of our six scientific programs. Program Leaders will select the award aligned to their program, and therefore will not serve as project PI. Projects must be focused on the establishment or support of a collaborative effort by a team of 2 or more independent investigators from the case Case CCC research program. The goal is to submit a federal team science grant application.
In The News
Cleveland 19 News- May 31, 2021
Cancer doctors at Case Western Reserve University, University Hospitals, and the Cleveland Clinic have a message for parents and young adults: Remember to get an HPV vaccination.
OncLive - June 1, 2021
University Hospitals' Paolo Caimi, MD discusses what lies ahead for loncastuximab tesirine and how it fits into the rapidly changing treatment landscape of DLBCL in an interview with OncLive. Dr. Caimi is a member of the Case CCC.
From The NIH
Weekly NIH Funding Opportunities and Notices
COVID-19 Funding Opportunities and Notices
Have something to share?
Use the button below to submit all your news, publications, events, announcements, lab openings and communications requests to the Case CCC Marketing and Communications team! We are here to help.